Phyllis Bellin is an accomplished finance professional currently serving as the Chief Financial Officer at Galimedix Therapeutics, Inc. since January 2018. Prior to this role, Phyllis held the position of Director of Finance & Administration at Medgenics Inc. from November 2005 to July 2015. Phyllis earned a Master of Business Administration (MBA) from Columbia Business School, where studies took place from 1976 to 1978.
This person is not in any teams
This person is not in any offices
Galimedix Therapeutics, Inc.
Galimedix Therapeutics is a Phase 2 neuropharmaceutical company developing novel first-in-class drugs with ground-breaking potential to slow or stop the progression of neurodegeneration and to improve function in glaucoma and dry AMD – leading causes of blindness – and also in Alzheimer’s disease.